Clinical Trial SWOG-S0820 Click to view printable page

Title

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III (Paces)

Principal Investigator

Jason Zell

Details

Learn More

For information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email ucstudy@uci.edu

If you would like more information regarding this specific trial, please leave your name, phone number, and email. We will contact you promptly.

Name: Email: Phone: